Search

everythinglearnresearchcommunity

for

Search:↓

Androgens play a key role in hair growth and disorders like baldness and excessive hairiness.

Androgens and androgen receptors are important for metabolic health, affecting how the body uses glucose and fats through mitochondrial function.

Finasteride can have lasting negative effects on brain function and behavior by disrupting neurosteroid production.

Metformin improves early signs of heart disease in women with PCOS and raises apelin levels, but doesn't significantly change artery thickness.

Male sexual differentiation is regulated independently, while female differentiation occurs in an androgenic environment, affecting conditions like congenital adrenal hyperplasia.

5α‐reductase isozymes are crucial for prostate development and health, and targeting them can help prevent and treat prostate issues.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.

Creating stronger blockers for skin enzymes might lead to better treatment for conditions like acne and excessive hair growth.

Hormone therapy for trans individuals is effective and generally safe in the short term.

Sebocytes play a key role in controlling androgen levels in human skin.

Low-Level Laser Therapy is effective and safe for hair growth with minimal side effects.

Male hormones, particularly DHT, are linked to male pattern hair loss, and treatments like finasteride can help, but they don't work for postmenopausal women's hair loss, which may have different causes.

Finasteride safely lowers DHT levels without affecting testosterone.

Too much androgen can cause hair loss; finasteride may help.

Estrogen replacement can improve skin health in menopausal women but doesn't reverse sun damage or prevent hair loss.

Higher levels of unbound testosterone are linked to increased insulin resistance, especially in women with polycystic ovary syndrome.

Estrogen Receptor ß (ERß) is the main hormone controller in human skin and hair follicles, not Estrogen Receptor α (ERα) or the Androgen Receptor (AR).

Targeting androgen receptors could be a promising way to treat skin disorders with fewer side effects.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

Women with PCOS and higher androgen levels are more likely to have fatty liver disease.

Women with PCOS are more than twice as likely to develop nonalcoholic fatty liver disease.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

Too much male hormone is the main cause of Polycystic Ovary Syndrome.

Low-dose oral minoxidil and spironolactone combo effectively reduces hair loss and improves hair density in women.

Spironolactone effectively reduces hair growth in women with hirsutism and is generally well-tolerated.

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

Women with PCOS have higher androgen levels that decrease with age but are still higher than in women without PCOS.

Securinine and ajmaline may effectively treat liver cancer, with securinine being less toxic to normal cells.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.